Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield(TM)) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India. A community-based cohort study was conducted from May to September 2021 in a selected geographic area in Chennai. The esti...

Descripción completa

Detalles Bibliográficos
Autores principales: Murali, Sharan, Sakthivel, Manikandanesan, Pattabi, Kamaraj, Venkatasamy, Vettrichelvan, Thangaraj, Jeromie Wesley Vivian, Shete, Anita, Varghese, Alby John, Arjun, Jaganathan, Kumar, Chethrapilly Purushothaman Girish, Yadav, Pragya D, Sahay, Rima, Majumdar, Triparna, Dudhmal, Manisha, Sivalingam, Azhagendran, Dhanapal, Sudha Rani, Durai Samy, Augustine, Radhakrishnan, Vijayaprabha, Muni Krishnaiah, Murali Mohan, Arunachalam, Suresh, Gandhi, Punita Muni Krishna, Govindasamy, Elavarasu, Chinnappan, Prabhakaran, Sekar, Dhana Priya Vadhani, Marappan, Prakash, Pounraj, Ezhil, Ganeshkumar, Parasuraman, Jagadeesan, Murugesan, Narnaware, Manish, Bedi, Gagandeep Singh, Kaur, Prabhdeep, Murhekar, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228854/
https://www.ncbi.nlm.nih.gov/pubmed/35746578
http://dx.doi.org/10.3390/vaccines10060970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228854/
https://www.ncbi.nlm.nih.gov/pubmed/35746578
http://dx.doi.org/10.3390/vaccines10060970

Ejemplares similares